TAK

EquitiesLive

Tokenized Takeda Pharmaceutical

Tokenized Takeda Pharmaceutical, on-chain exposure to the underlying equity.

See TAK on /markets →Underlying ticker: TAK

Key facts

Wrapped symbol
TAK
Underlying
TAK
Asset class
Equities
Custodian
Interactive Brokers
Chains
Base, Arbitrum, Ethereum
Distribution treatment
Total return, accrued to NAV
Attestation cadence
Daily
Issuer
Flo Global Markets Ltd. (BVI)
Asset SPC
Flo Capital SPC (Cayman)
Prospectus
FMA-approved Liechtenstein base prospectus

How TAK resolves to TAK

Each TAK on-chain represents a unit claim on the underlying Takeda Pharmaceutical held in a segregated brokerage account. The issuer, custodian, and prospectus are the same for every Flo token; only the underlying differs.

  1. 01

    Issuance

    Flo Global Markets Ltd. (BVI) issues TAK under the FMA-approved Liechtenstein base prospectus, EEA-passported across 30 states.

  2. 02

    Custody

    The underlying Takeda Pharmaceutical is held by Flo Capital SPC (Cayman) in a segregated brokerage account at Interactive Brokers, an SEC-registered broker-dealer.

  3. 03

    Settlement

    TAK settles on-chain on Base, Arbitrum, Ethereum. Cross-chain transfers route through Chainlink CCIP.

  4. 04

    Attestation

    Reserves are attested daily by an independent auditor and published on the Flo transparency surface.

Mint TAK with one SDK call

Every Flo-issued token shares the same six SDK methods. Mint, redeem, supply, withdraw, borrow, repay.

POST /v1/mint

{
  "asset": "TAK",
  "notional_usdc": "1000.00",
  "slippage_bps": 50,
  "settlement": {
    "currency": "USDC",
    "chain": "base"
  }
}

Where TAK lives today

Flo distributes through partners. The same TAK on-chain is the asset every partner integrates against; partner UIs may relabel it for their own brand.

Partner integrations in build

No live partner is distributing TAK yet. Twelve integrations are in build across exchanges, wallets, fintechs, neobanks, and asset managers. Partners are listed here only after they ship.

Audits

Four independent firms, $250K bug bounty

Sherlock, Halborn, Cantina, and Cyfrin have audited the smart contracts that issue and settle TAK. The same contracts power every Flo-issued token; one audit covers the catalogue.

Read the audit reports →

Prospectus

FMA-approved Liechtenstein base prospectus

TAK is issued under a base prospectus approved by the Liechtenstein Financial Market Authority and passportable across all 30 EEA states.

Open the prospectus →

Risks

TAK carries the market risk of the underlying Takeda Pharmaceutical, plus the structural risks common to every issuer-wrapped token: custody concentration, smart-contract risk, oracle dependency, and prospectus jurisdiction. Read the full risk section in the base prospectus before integrating or holding.